Jeremy A. Tigan

I'll research this attorney's background and practice.

Let me dig into notable outcomes and PTAB experience.

Jeremy A. Tigan — patent litigation summary

Practice focus. Tigan is an intellectual property litigation partner at Morris, Nichols, Arsht & Tunnell LLP in Wilmington, Delaware, focusing on patent infringement and trade secret disputes in the District of Delaware. His technology mix spans semiconductor/RF devices (Qorvo's bulk acoustic wave filter litigation), software and networking, pharmaceuticals (a long-running Hatch-Waxman and ANDA docket for Veloxis, plus Otsuka/Avanir and Mitsubishi Tanabe matters), robotics, and consumer products (Baby Jogger). Chambers describes his practice as concentrated in semiconductors, software, pharmaceuticals, and consumer products, and notes bench and jury trial experience in D. Del. with appeals to the Third and Federal Circuits. He served as head of the firm's IP litigation group from 2020–2024.

Side of the "v." Tigan's tracked appearances split roughly evenly — 19 plaintiff-side and 15 defendant-side — and that tracks his actual practice. He is a regular plaintiff's-side counsel for innovator pharmaceutical companies in ANDA cases (the Veloxis and Otsuka/Avanir filings) and for technology plaintiffs such as Qorvo, while also defending operating companies in tech cases (Beckman Coulter v. Cytek, Datacloud v. Microsoft, Nokia Technologies). He is not an NPE/PAE-focused filer; his plaintiff-side work is predominantly brand, university, or operating-company enforcement. Most of his tracked roles are as Delaware/local counsel (roughly two-thirds), with a minority as lead counsel. The tracked list contains apparent duplicates and several "Untitled case" entries, so the raw counts should be read as approximate.

Firm and career context. Tigan joined Morris Nichols in 2008 and was elected partner effective January 1, 2017. All of his tracked patent litigation appearances are at Morris Nichols; no prior firm is identified in public sources. Before law school he worked in the investigatory arm of the National Association of Securities Dealers. He is admitted in Delaware (2008), the District of Delaware (2009), the Third Circuit (2013), and the Federal Circuit (2011), and holds a J.D., cum laude, from George Mason University School of Law (2007; now Antonin Scalia Law School), an M.A. in political science from George Washington University (2004), and a B.S. from the University of Oregon (2002).

Notable matters and results. His most prominent results are in Delaware trials: Qorvo, Inc. v. Akoustis Technologies, Inc. — a May 2024 jury verdict awarding Qorvo roughly $38.6M (about $31.3M unjust enrichment on 37 misappropriated trade secrets, $7M exemplary damages, and ~$280K patent infringement), followed by a permanent injunction, an approximately $11.7M attorneys' fee award, and an amended final judgment in November 2024; and Northwestern University v. Universal Robots — a September 2024 jury verdict of $6.6M on three collaborative-robot patents, settled about a month later (the Northwestern collaboration docket also included an IPR filed by ABB that was not instituted, per co-counsel's public description of the matter). Earlier, he was an associate on the Morris Nichols team that won a 2012 jury verdict for LadaTech against Illumina on DNA amplification patents. The firm also credits him on the 2025 Delaware summary judgment of noninfringement for bluebird bio.

PTAB / IPR. His patent litigation work regularly involves parallel PTAB proceedings — for example, briefing discretionary denial and stay issues in Baby Jogger v. Baby Generation (Mockingbird), where IPRs were filed against all asserted patents — and his tracked profile includes work on a Tecan Genomics PTAB-related matter. Public records do not show him as a frequent first-chair PTAB practitioner; his IPR exposure appears to be as district court counsel coordinating with parallel challenges rather than as a standing PTAB advocate.